CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
CMPI
Delisted
CMPI was delisted on the 27th of May, 2022.
26 hedge funds and large institutions have $54.8M invested in Checkmate Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Holders
26
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$41.9K | |
| 2 | +$5.58K | |
| 3 | +$3.47K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.56K |
| 5 |
State Street
Boston,
Massachusetts
|
+$969 |
Top Sellers
| 1 | -$486K | |
| 2 | -$268K | |
| 3 | -$67.4K | |
| 4 |
Millennium Management
New York
|
-$31K |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$23.3K |